Entospletinib (GS-9973) is a potent and selective oral inhibitor of spleen tyrosine kinase (Syk) with an IC50 of 7.7 nM. It is a research tool for investigating hematological cancers and autoimmune disorders, showing activity in both cellular assays and animal models of disease.